285 related articles for article (PubMed ID: 29295756)
1. A virus-like particle vaccine confers protection against enterovirus D68 lethal challenge in mice.
Dai W; Zhang C; Zhang X; Xiong P; Liu Q; Gong S; Geng L; Zhou D; Huang Z
Vaccine; 2018 Jan; 36(5):653-659. PubMed ID: 29295756
[TBL] [Abstract][Full Text] [Related]
2. Enterovirus D68 virus-like particles expressed in Pichia pastoris potently induce neutralizing antibody responses and confer protection against lethal viral infection in mice.
Zhang C; Zhang X; Zhang W; Dai W; Xie J; Ye L; Wang H; Chen H; Liu Q; Gong S; Geng L; Huang Z
Emerg Microbes Infect; 2018 Jan; 7(1):3. PubMed ID: 29323105
[TBL] [Abstract][Full Text] [Related]
3. A virus-like particle vaccine protects mice against coxsackievirus A10 lethal infection.
Zhou Y; Zhang C; Liu Q; Gong S; Geng L; Huang Z
Antiviral Res; 2018 Apr; 152():124-130. PubMed ID: 29470994
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and performance of an enterovirus 71 virus-like-particle vaccine in nonhuman primates.
Lim PY; Hickey AC; Jamiluddin MF; Hamid S; Kramer J; Santos R; Bossart KN; Cardosa MJ
Vaccine; 2015 Nov; 33(44):6017-24. PubMed ID: 26271825
[TBL] [Abstract][Full Text] [Related]
5. A neonatal mouse model of Enterovirus D68 infection induces both interstitial pneumonia and acute flaccid myelitis.
Sun S; Bian L; Gao F; Du R; Hu Y; Fu Y; Su Y; Wu X; Mao Q; Liang Z
Antiviral Res; 2019 Jan; 161():108-115. PubMed ID: 30503887
[TBL] [Abstract][Full Text] [Related]
6. A Mouse Model of Enterovirus D68 Infection for Assessment of the Efficacy of Inactivated Vaccine.
Zhang C; Zhang X; Dai W; Liu Q; Xiong P; Wang S; Geng L; Gong S; Huang Z
Viruses; 2018 Jan; 10(2):. PubMed ID: 29385753
[TBL] [Abstract][Full Text] [Related]
7. Virus-like particle-based vaccine against coxsackievirus A6 protects mice against lethal infections.
Shen C; Ku Z; Zhou Y; Li D; Wang L; Lan K; Liu Q; Huang Z
Vaccine; 2016 Jul; 34(34):4025-31. PubMed ID: 27340093
[TBL] [Abstract][Full Text] [Related]
8. A Novel Neutralizing Antibody Specific to the DE Loop of VP1 Can Inhibit EV-D68 Infection in Mice.
Zheng H; Wang J; Li B; Guo L; Li H; Song J; Yang Z; Li H; Fan H; Huang X; Long H; Cheng C; Chu M; He Z; Yu W; Li J; Gao Y; Ning R; Li N; Yang J; Wu Q; Shi H; Sun M; Liu L
J Immunol; 2018 Nov; 201(9):2557-2569. PubMed ID: 30282753
[TBL] [Abstract][Full Text] [Related]
9. Induction of a high-titered antibody response using HIV gag-EV71 VP1-based virus-like particles with the capacity to protect newborn mice challenged with a lethal dose of enterovirus 71.
Wang X; Dong K; Long M; Lin F; Gao Z; Wang L; Zhang Z; Chen X; Dai Y; Wang H; Zhang H
Arch Virol; 2018 Jul; 163(7):1851-1861. PubMed ID: 29582164
[TBL] [Abstract][Full Text] [Related]
10. Combination of three virus-derived nanoparticles as a vaccine against enteric pathogens; enterovirus, norovirus and rotavirus.
Heinimäki S; Hankaniemi MM; Sioofy-Khojine AB; Laitinen OH; Hyöty H; Hytönen VP; Vesikari T; Blazevic V
Vaccine; 2019 Dec; 37(51):7509-7518. PubMed ID: 31585726
[TBL] [Abstract][Full Text] [Related]
11. A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice.
Ku Z; Liu Q; Ye X; Cai Y; Wang X; Shi J; Li D; Jin X; An W; Huang Z
Vaccine; 2014 Jul; 32(34):4296-303. PubMed ID: 24950363
[TBL] [Abstract][Full Text] [Related]
12. Vesicular stomatitis virus-based vaccines expressing EV71 virus-like particles elicit strong immune responses and protect newborn mice from lethal challenges.
Yan Q; Wu L; Chen L; Qin Y; Pan Z; Chen M
Vaccine; 2016 Jul; 34(35):4196-4204. PubMed ID: 27373596
[TBL] [Abstract][Full Text] [Related]
13. Immunization with phage virus-like particles displaying Zika virus potential B-cell epitopes neutralizes Zika virus infection of monkey kidney cells.
Basu R; Zhai L; Contreras A; Tumban E
Vaccine; 2018 Feb; 36(10):1256-1264. PubMed ID: 29395533
[TBL] [Abstract][Full Text] [Related]
14. A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge.
Liu Q; Yan K; Feng Y; Huang X; Ku Z; Cai Y; Liu F; Shi J; Huang Z
Vaccine; 2012 Oct; 30(47):6642-8. PubMed ID: 22959985
[TBL] [Abstract][Full Text] [Related]
15. EV-D68 virus-like particle vaccines elicit cross-clade neutralizing antibodies that inhibit infection and block dissemination.
Krug PW; Wang L; Shi W; Kong WP; Moss DL; Yang ES; Fisher BE; Morabito KM; Mascola JR; Kanekiyo M; Graham BS; Ruckwardt TJ
Sci Adv; 2023 May; 9(20):eadg6076. PubMed ID: 37196074
[TBL] [Abstract][Full Text] [Related]
16. EV71 virus-like particles produced by co-expression of capsid proteins in yeast cells elicit humoral protective response against EV71 lethal challenge.
Wang X; Xiao X; Zhao M; Liu W; Pang L; Sun X; Cen S; Yang BB; Huang Y; Sheng W; Zeng Y
BMC Res Notes; 2016 Jan; 9():42. PubMed ID: 26809443
[TBL] [Abstract][Full Text] [Related]
17. Recombinant virus-like particle presenting a newly identified coxsackievirus A10 neutralization epitope induces protective immunity in mice.
Dai W; Xiong P; Zhang X; Liu Z; Chen J; Zhou Y; Ye X; Zhang C
Antiviral Res; 2019 Apr; 164():139-146. PubMed ID: 30817941
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of enterovirus‑71 (EV71) virus‑like particle vaccine against lethal EV71 infection in a neonatal mouse model.
Cao L; Mao F; Pang Z; Yi Y; Qiu F; Tian R; Meng Q; Jia Z; Bi S
Mol Med Rep; 2015 Aug; 12(2):2473-80. PubMed ID: 25936344
[TBL] [Abstract][Full Text] [Related]
19. Current Understanding of Humoral Immunity to Enterovirus D68.
Vogt MR; Crowe JE
J Pediatric Infect Dis Soc; 2018 Dec; 7(suppl_2):S49-S53. PubMed ID: 30590621
[TBL] [Abstract][Full Text] [Related]
20. An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.
Urakami A; Ngwe Tun MM; Moi ML; Sakurai A; Ishikawa M; Kuno S; Ueno R; Morita K; Akahata W
J Virol; 2017 Dec; 91(23):. PubMed ID: 28956764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
